Integra Lifesciences Holdings Corp (IART)
24.91
+0.80
(+3.32%)
USD |
NASDAQ |
Nov 05, 16:00
24.91
0.00 (0.00%)
After-Hours: 19:06
Integra Lifesciences Holdings Cash from Financing (Quarterly): -93.75M for June 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -93.75M |
| March 31, 2024 | 358.68M |
| December 31, 2023 | -6.89M |
| September 30, 2023 | -49.66M |
| June 30, 2023 | -10.69M |
| March 31, 2023 | -162.68M |
| December 31, 2022 | -97.70M |
| September 30, 2022 | -7.642M |
| June 30, 2022 | -13.15M |
| March 31, 2022 | -133.46M |
| December 31, 2021 | 0.521M |
| September 30, 2021 | 1.743M |
| June 30, 2021 | -97.48M |
| March 31, 2021 | -3.015M |
| December 31, 2020 | 21.22M |
| September 30, 2020 | -33.05M |
| June 30, 2020 | -28.55M |
| March 31, 2020 | 162.00M |
| December 31, 2019 | -81.99M |
| September 30, 2019 | 81.02M |
| June 30, 2019 | -13.19M |
| March 31, 2019 | 5.393M |
| December 31, 2018 | -84.06M |
| September 30, 2018 | -39.84M |
| June 30, 2018 | -36.09M |
| Date | Value |
|---|---|
| March 31, 2018 | -20.89M |
| December 31, 2017 | 664.21M |
| September 30, 2017 | 286.37M |
| June 30, 2017 | 33.32M |
| March 31, 2017 | 185.04M |
| December 31, 2016 | 13.76M |
| September 30, 2016 | -19.80M |
| June 30, 2016 | -19.03M |
| March 31, 2016 | 9.952M |
| December 31, 2015 | -17.76M |
| September 30, 2015 | 245.31M |
| June 30, 2015 | 34.42M |
| March 31, 2015 | -13.83M |
| December 31, 2014 | 7.638M |
| September 30, 2014 | -13.19M |
| June 30, 2014 | 1.062M |
| March 31, 2014 | 243.17M |
| December 31, 2013 | -0.488M |
| September 30, 2013 | 0.184M |
| June 30, 2013 | 19.07M |
| March 31, 2013 | 0.257M |
| December 31, 2012 | 2.817M |
| September 30, 2012 | 0.46M |
| June 30, 2012 | 21.03M |
| March 31, 2012 | -12.56M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-162.68M
Minimum
Mar 2023
358.68M
Maximum
Mar 2024
-14.50M
Average
-13.15M
Median
Jun 2022
Cash from Financing (Quarterly) Benchmarks
| Abbott Laboratories | -1.576B |
| Perspective Therapeutics Inc | 122.08M |
| Retractable Technologies Inc | -0.1329M |
| Xtant Medical Holdings Inc | 6.434M |
| Catheter Precision Inc | 0.267M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 40.40M |
| Cash from Investing (Quarterly) | -322.20M |
| Free Cash Flow | 58.89M |
| Free Cash Flow Per Share (Quarterly) | 0.1381 |
| Free Cash Flow to Equity (Quarterly) | 41.39M |
| Free Cash Flow to Firm (Quarterly) | 21.80M |
| Free Cash Flow Yield | 3.02% |